DecisionBase
Key Users
Global Market Research U.S. Market Research Biz Development (Licensing) Brand Management Pricing & Reimbursement
Empowering Decision Makers with Robust Interactive Data and Analysis
Drug development isn’t what it used to be. Gone are the days of relying on blockbusters. Instead, the drug industry is faced with identifying incremental drug improvements that will be commercially compelling.
In response to these changing times, Decision Resources has revamped its data and analysis tool, DecisionBase, to better address the needs of the drug industry. DecisionBase 2010 combines market forecasts with clinical and commercial end points to assess market share projections in 35 indications. These outputs are driven by quantitative and qualitative primary research.
DecisionBase 2010 provides detailed market share, patient share and price-per-day projections for key current and emerging drugs. The market share projections are based on results from prescriber surveys that compare physicians’ expectations of a potential target product profile with an emerging product profile of the leading drugs in development. The forecast is built on evaluation of commercial and clinical drivers that impact the market. In the commercial environment, we examine pricing, reimbursement, regulatory issues and drug labeling. In the clinical environment, we evaluate clinical differentiators of key current and emerging therapies, factors that influence prescribing decisions and drug choice, patient population, country-specific medical practice and current therapies’ impact on quality of life measures.
Each indication assesses:
- Prescription patterns, patient share and market potential of two physician-built target product profiles of a drug fulfilling a key unmet need
- Patient share and usage share of emerging product profiles
- Clinical information including remaining unmet need, key clinical trial end points, quality of life measures and comparison of the clinical profiles of current and emerging therapies
- Market forecast information including diagnosis rates, drug-treated population numbers, patient share, price-per-day and compliance rates
- Commercial information including pricing, reimbursement, labeling and regulatory history
Round-Up
Register to receive the Round-Up with our latest offers!
Decision Resources Group companies include: